AlphaTON Capital (NASDAQ: ATON), a digital asset treasury firm developing the TON and Telegram ecosystem, has received public recognition from Nasdaq for its blockchain-based initiative to fund cancer research. The announcement appeared on the Nasdaq Tower in Times Square, highlighting growing interest in tokenized healthcare financing. Through its partnership with Cyncado Therapeutics, AlphaTON Capital is using blockchain and asset tokenization to connect investors with oncology research programs. The model offers transparent fund allocation, improved liquidity, and lower participation thresholds, aiming to accelerate the development of new cancer treatments. Nasdaq’s acknowledgment underscores increasing institutional acceptance of tokenized assets. AlphaTON Capital plans to expand its tokenization framework to other therapeutic fields and research institutions in the near future. Image: Freepik